Table 4.
Cumulative 8-year revision rates of cemented fixed bearing total knee arthroplasties for osteoarthritis with cruciate retaining (CR) or posterior stabilized (PS) knee system, stratified for sex, age, and ASA score, in the Netherlands in 2007–2016 (n = 133,841)
CR TKA system |
PS TKA system |
|||
---|---|---|---|---|
Sex, age | 8-year revision |
8-year revision |
||
ASA-score | n | rate (%) (CI) | n | rate (%) (CI) |
Male, < 60 years | ||||
ASA I | 1,561 | 7.2 (5.6–9.2)a | 1,753 | 12.1 (9.8–15.0)a |
ASA II | 2,105 | 7.8 (6.0–10.3)a | 2,605 | 14.4 (11.4–18.1)a |
ASA III–IV | 236 | 6.1 (3.3–11.3) | 347 | 13.0 (7.7–22.2) |
Total | 4,015 | 7.2 (6.1–8.5)a | 4,842 | 12.7 (11.1–14.5)a |
Male, 60–69 years | ||||
ASA I | 1,975 | 2.7 (2.0–3.7)a | 2,161 | 5.6 (4.4–7.2)a |
ASA II | 5,127 | 4.3 (3.5–5.2)a | 6,408 | 6.5 (5.6–7.7)a |
ASA III–IV | 890 | 4.9 (3.3–7.5) | 1,057 | 7.6 (5.5–10.6) |
Total | 8,193 | 4.0 (3.4–4.7)a | 9,835 | 6.3 (5.6–7.1)a |
Male, ≥ 70 years | ||||
ASA I | 1,091 | 3.4 (2.0–5.6) | 1,310 | 5.5 (4.1–7.5) |
ASA II | 5,766 | 2.3 (1.9–2.9) | 6,765 | 3.4 (2.8–4.2) |
ASA III–IV | 1,546 | 2.2 (1.5–3.4) | 2,034 | 4.0 (2.9–5.5) |
Total | 8,621 | 2.6 (2.2–3.2)a | 10,365 | 4.0 (3.4–4.6)a |
Female, < 60 years | ||||
ASA I | 1,717 | 8.3 (6.7–10.4) | 2,124 | 8.7 (7.1–10.7) |
ASA II | 3,444 | 7.5 (6.3–8.9) | 4,579 | 9.6 (8.3–11.0) |
ASA III–IV | 533 | 8.9 (4.4–18.1) | 728 | 11.9 (8.7–16.4) |
Total | 5,876 | 8.2 (7.2–9.3) | 7,648 | 9.4 (8.5–10.5) |
Female, 60–69 years | ||||
ASA I | 2,690 | 5.7 (4.6–7.2) | 3,070 | 5.4 (4.2–7.0) |
ASA II | 9,030 | 4.0 (3.5–4.7)a | 11,011 | 7.2 (6.2–8.3)a |
ASA III–IV | 1,410 | 5.9 (4.3–8.1) | 1,916 | 7.9 (6.0–10.5) |
Total | 13,499 | 4.7 (4.2–5.3) | 16,400 | 6.6 (6.0–7.3) |
Female, ≥ 70 years | ||||
ASA I | 2,259 | 2.0 (1.4–2.8)a | 2,524 | 4.4 (3.5–5.6)a |
ASA II | 14,016 | 3.0 (2.7–3.5)a | 16,562 | 4.0 (3.6–4.5)a |
ASA III–IV | 3,280 | 3.1 (2.4–4.0) | 4,120 | 3.8 (3.0–4.7) |
Total | 20,187 | 2.9 (2.6–3.3)a | 23,984 | 4.0 (3.6–4.3)a |
TKA: total knee arthroplasty.
p < 0.05 for PS compared with CR TKAs.